Skip to main content
Ashraf Badros, MD, Oncology, Baltimore, MD

AshrafZarifBadrosMD

Oncology Baltimore, MD

Hematologic Oncology

Professor, Medicine, University of Maryland School of Medicine

Overview of Dr. Badros

Dr. Ashraf Badros is an oncologist in Baltimore, MD and is affiliated with University of Maryland Medical Center. He received his medical degree from Ain Shams University Faculty of Medicine and has been in practice 32 years. Dr. Badros accepts several types of health insurance, listed below. He is one of 102 doctors at University of Maryland Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Georgetown University Hospital
    Georgetown University HospitalFellowship, Medical Oncology, 1994 - 1996
  • MedStar Health/Harbor Hospital
    MedStar Health/Harbor HospitalResidency, Internal Medicine, 1990 - 1993
  • Ain Shams University Faculty of Medicine
    Ain Shams University Faculty of MedicineClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1991 - 2026
  • AR State Medical License
    AR State Medical License 1998 - 2002
  • DC State Medical License
    DC State Medical License 1994 - 1998
  • NY State Medical License
    NY State Medical License 1993 - 1994
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
    Ashraf Z. Badros, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
    Ashraf Z. Badros, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)
    Ashraf Z. Badros, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Intravesicular Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis (BKV-HC) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Novel Approaches to Newly Diagnosed Plasma Cell Dyscrasias 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • DARZALEX® (Daratumumab)-Based Maintenance Regimens Show Clinically Meaningful Deep and Durable Responses in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma
    DARZALEX® (Daratumumab)-Based Maintenance Regimens Show Clinically Meaningful Deep and Durable Responses in Transplant-Eligible Patients with Newly Diagnosed Multiple MyelomaSeptember 27th, 2024
  • International Myeloma Foundation Launches Baltimore-Area Campaign to Raise Disease Awareness and Improve Outcomes in the African-American Community
    International Myeloma Foundation Launches Baltimore-Area Campaign to Raise Disease Awareness and Improve Outcomes in the African-American CommunitySeptember 9th, 2021
  • Pembrolizumab Combo Active in Relapsed/Refractory Myeloma
    Pembrolizumab Combo Active in Relapsed/Refractory MyelomaMay 16th, 2017

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CareFirst BCBS Maryland POS
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment